Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Amyotrophic Lateral Sclerosis, Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Cell imaging & tracking | UCSD |
![]() |
Research Insights | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | Lineage Cell |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Other | Embryonic Stem Cell | Cell imaging & tracking | UC Berkeley |
![]() |
Tool/Resources/Bottleneck | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
Canavan Disease | iPS Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Other | Donor cell therapy | jCyte |
![]() |
Clinical Trial, Phase 2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Gene-modified, donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Neurological Disorders, Zika virus |
Adult Stem Cell, iPS Cell |
Vaccine | UCLA |
![]() |
Development Candidate | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cancer | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Personalized cell therapy | BrainStorm |
![]() |
Clinical Trial, Phase 3 | |
Blood Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Angiocrine |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | ViaCyte |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Arthritis, Osteoarthritis |
Adult Stem Cell | Small molecule therapy | Calibr |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Cancer, Bone Marrow Transplant and Viral Infection |
Adult Stem Cell | Donor cell therapy | CHLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Vascular Disease | iPS Cell | Personalized cell therapy | PAVIR |
![]() |
Proof of Concept, Research Insights | |
Hemophilia A | Adult Stem Cell | Gene modification | COH |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | ViaCyte |
![]() |
Development Candidate | |
Muscular Dystrophy |
Embryonic Stem Cell, iPS Cell |
Personalized cell therapy | UCLA |
![]() |
Development Candidate | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Spinal Cord Injury | Adult Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Beta Thalassemia | Adult Stem Cell | Gene-modified, personalized cell therapy | Sangamo |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | Orchard Therapeutics |
![]() |
Clinical Trial, Phase 2 | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
![]() |
Regulated Lab Test, Ready for Validation | |
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND |